Batory Foods, BioHarvest’s exclusive USA distributor, receives the first Purchase Order from “Designs for Health”.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announces the first significant win for its VINIA® B2B sales division. Batory Foods, the exclusive US distributor of VINIA®, has received the first Purchase Order of 60kg of VINIA® from “Designs for Health”, a trusted source of health care professionals for research-backed health care nutritional products of superior quality. After a thorough review process, “Designs for Health” identified VINIA® as a key nutritional ingredient to utilize in its delivery of best-in-class science-based nutrition to its customers. VINIA®, a red grape cell product containing the entire matrix of polyphenols contained in red grapes with a high concentration of Piceid Resveratrol and other key Polyphenols in their naturally occurring state, has been scientifically validated in clinical trials to have important functional benefits for the body and accordingly will be integrated into a number of “Designs for Health” nutritional products.


“At ‘Designs for Health’, we use the motto and tag-line ‘Science First’, and we mean it,” said Dr. David M. Brady, Chief Medical Officer of Designs for Health. “This includes the raw materials and suppliers we chose to work with as we develop our world-renowned products for physicians and health care providers to recommend to their patients. We could not have found a better partner than BioHarvest, and a better material than VINIA®, in meeting these requirements. We only work with partners and collaborators who share our commitment to science and efficacy, as well as our ethics and values”.

Kelley Karas, Corporate Director of Quality at “Designs for Health”, added “We are happy to announce that BioHarvest has passed our supplier qualification process and their VINIA® material has met our strict specifications. These are based on the highest standards through thorough qualification and testing beyond the requirements of 21 CFR 111. VINIA® adheres to our principle of bringing the highest quality supplements”.

Vince Pinneri, President of Batory Foods stated: “The first Purchase Order for VINIA® is a sign of more to come. Together with BioHarvest, we were able to easily communicate the superiority of VINIA® and translate it into significant value for ‘Designs for Health’. We are convinced that Batory can identify many more customers who would appreciate the strong scientific and clinical support for BioHarvest’s products. We are pleased by this partnership with BioHarvest and looking forward to a successful 2021”

“This significant win validates our B2B strategy” stated Ilan Sobel, CEO of BHSC, adding “This initial Purchase Order is a clear indicator that we made a great choice in selecting Batory as our exclusive distributor in the US. This partnership is yielding results in record time considering the B2B sales cycle. Furthermore, the selection of VINIA® by “Designs for Health” is an endorsement of the superiority of our BioFarming technology for the consistent and quality production of metabolites such as Resveratrol”.

Bioharvest and Batory Foods continue to build the B2B Vinia sales pipeline for 2021, and the Company believes that this first US sale, combined with the strength of B2C sales in Israel and pending launch of VINIA® B2C in the US in April 2021, provides BioHarvest with confidence that it will achieve 2021 revenue targets and “break-even” financial model for the Nutraceutical vertical.

About BioHarvest Sciences Inc.

Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company’s technology is non-GMO and has already been validated by VINIA®, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.‘s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes. Visit: www.bioharvest.com.

Readership, please note Dr. David Brady is also a member of the BioHarvest Advisory Board

BioHarvest Sciences Inc.
Ilan Sobel, Chief Executive Officer

For further information, please contact:
Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186
Email: dave@bioharvest.com

Twitter
Facebook
LinkedIn
YouTube

Forward-Looking Statements

Information set forth in this news release includes forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. A purchase order is not a guarantee of payment. The Company recognises revenue when payment is received and makes the required allowances for possible returns. There are no assurances of additional orders from ‘Designs for Health’ or other US purchasers and no assurances the Company will meet its 2021 targets. There is also no assurance the Company will generate significant revenue in the global nutraceutical and dietary supplements markets. There is no assurance that we will achieve our objective of being a leading supplier of Cannabis. Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. Projected sales of Cannabis will require the company to obtain production and/or export licensing which cannot be assured.

All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/70903

News Provided by Newsfile via QuoteMedia

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less